239 related articles for article (PubMed ID: 28401452)
1. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
[TBL] [Abstract][Full Text] [Related]
2. The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Gołębiowski P; Sobieszek G; Małecka-Massalska T
Support Care Cancer; 2020 Feb; 28(2):531-540. PubMed ID: 31076897
[TBL] [Abstract][Full Text] [Related]
3. Status of hydration assessed by bioelectrical impedance analysis: a valuable predictive factor for radiation-induced oral mucositis in head and neck cancer patients.
Brzozowska A; Mlak R; Gołębiowski P; Małecka-Massalska T
Clin Transl Oncol; 2019 May; 21(5):615-620. PubMed ID: 30327938
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of regulatory region of GHRL gene (-2531C>T) as a promising predictive factor for radiotherapy-induced oral mucositis in patients with head neck cancer.
Brzozowska A; Homa-Mlak I; Mlak R; Gołębiowski P; Mazurek M; Ciesielka M; Małecka-Massalska T
Head Neck; 2018 Aug; 40(8):1799-1811. PubMed ID: 29566446
[TBL] [Abstract][Full Text] [Related]
5. RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Małecka-Massalska T
Cancer Biomark; 2018; 22(4):657-667. PubMed ID: 29865035
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of regulatory region of APEH gene (c.-521G>C, rs4855883) as a relevant predictive factor for radiotherapy induced oral mucositis and overall survival in head neck cancer patients.
Brzozowska A; Mlak R; Homa-Mlak I; Gołębiowski P; Mazurek M; Ciesielka M; Małecka-Massalska T
Oncotarget; 2018 Jul; 9(51):29644-29653. PubMed ID: 30038710
[TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra.
Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of TNFRSF1 A may act as a predictor of severe radiation-induced oral mucositis and a prognosis factor in patients with head and neck cancer.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Gołębiowski P; Korzeb D; Rahnama-Hezavah M; Małecka-Massalska T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Sep; 130(3):283-291.e2. PubMed ID: 32561252
[TBL] [Abstract][Full Text] [Related]
10. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
11. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
12. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.
Franco P; Martini S; Di Muzio J; Cavallin C; Arcadipane F; Rampino M; Ostellino O; Pecorari G; Garzino Demo P; Fasolis M; Airoldi M; Ricardi U
Med Oncol; 2017 May; 34(5):81. PubMed ID: 28386836
[TBL] [Abstract][Full Text] [Related]
13. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
[TBL] [Abstract][Full Text] [Related]
14. TNFRSF1A Gene Polymorphism (−610 T > G, rs4149570) as a Predictor of Malnutrition and a Prognostic Factor in Patients Subjected to Intensity-Modulated Radiation Therapy Due to Head and Neck Cancer.
Homa-Mlak I; Mlak R; Mazurek M; Brzozowska A; Powrózek T; Rahnama-Hezavah M; Małecka-Massalska T
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884467
[TBL] [Abstract][Full Text] [Related]
15. Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.
Ren JH; Dai XF; Yan GL; Jin M; Liu CW; Yang KY; Wu G; Ma CM
Int J Radiat Biol; 2014 Mar; 90(3):256-61. PubMed ID: 24350917
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract][Full Text] [Related]
17. Relationship between TNF-α -1031T/C gene polymorphism, plasma level of TNF-α, and risk of cachexia in head and neck cancer patients.
Powrózek T; Mlak R; Brzozowska A; Mazurek M; Gołębiowski P; Małecka-Massalska T
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1423-1434. PubMed ID: 29802455
[TBL] [Abstract][Full Text] [Related]
18. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis.
Li P; Du CR; Xu WC; Shi ZL; Zhang Q; Li ZB; Fu S
Radiat Oncol; 2013 Jun; 8():155. PubMed ID: 23803252
[TBL] [Abstract][Full Text] [Related]
19. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
